The information highlighted (if any) are the most recent updates for this brand.
Since adequate human reproduction studies have not been done with corticosteroids, the use of these drugs in pregnancy, nursing mothers or women of childbearing potential requires that the possible benefits of the drug be weighed against the potential hazards to the mother and the embryo, fetus or nursing infant. Infants born of mothers who have received substantial doses of corticosteroids during pregnancy should be carefully observed for signs of hypoadrenalism. It is not known whether Kenacort is excreted in breast milk. However, the other corticosteroids have been shown to be excreted in small quantities in human breast milk.